[Taylor&Francis] Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer |
|
This post will be closed automatically in 2026-11-05 18:20
Best Answer
1 hour(s) ago
|
| |
30
Classification of Toothbrush-Handle Evidence Using Differential Raman Spectroscopy Combined with Peak-Region-Guided Chemometrics
30
Play-Based Approaches to Preschool Assessment
30
A leader-level Analysis of South Korea's push for the reclamation of wartime operational control: Focusing on ideology and cognitive biases
30
Pragmatics in Human每Computer Interaction: A Systematic Literature Review
30
[Single chapter]Business Process Automation in Micro-Enterprises
